Minorities substantially underrepresented in pancreatic cancer clinical trials
Minorities substantially underrepresented in pancreatic cancer clinical trials Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase of study, according to research that was selected for presentation at Digestive Disease Week ® (DDW) 2021. We see disparities in representation across all kinds of clinical trials, so we were not surprised to see that it also occurs in pancreatic cancer trials. But hopefully we can ...